from Reuters: Health News https://reut.rs/2K2zAw8
U.S. approves $2 million Novartis gene therapy for rare, deadly muscle disorder
ZURICH/NEW YORK - Swiss drugmaker Novartis won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, the company said on Friday, a one-time treatment expected to push the pricing boundary for rare diseases to new heights.
from Reuters: Health News https://reut.rs/2K2zAw8
from Reuters: Health News https://reut.rs/2K2zAw8
Subscribe to:
Post Comments (Atom)
-
Sometimes the best paleo snacks are frozen ones. Wether it’s because of hot weather, after a workout or just because you want to feel light ...
-
Let’s be honest: we put our hair through a lot — from heat styling to dye jobs and loading it with product. So, it’s about time our strands...
-
Paleo Grubs Paleo Grubs - She told me that she adds molasses to give it that specific taste. She brought the bottle out for me to dip my ...
No comments:
Post a Comment